PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institut für Virologie, Freie Universität Berlin, Berlin, Germany.\', \'Institut für Tierpathologie, Freie Universität Berlin, Berlin, Germany; Tiermedizinisches Zentrum für Resistenzforschung, Freie Universität Berlin, Berlin, Germany.\', \'Institut für Tierpathologie, Freie Universität Berlin, Berlin, Germany.\', \'Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.\', \'Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.\', \'Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland; Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.\', \'Institut für Virologie, Freie Universität Berlin, Berlin, Germany; Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.\', \'Institut für Virologie, Freie Universität Berlin, Berlin, Germany. Electronic address: dusan.kunec@fu-berlin.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(21)00920-710.1016/j.celrep.2021.109493
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 34320400
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
is ?:relation_isRelatedTo_publication of
?:title
  • Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all